Latest news with #AlkemLaboratories
Business Upturn
4 days ago
- Business
- Business Upturn
Alkem Labs shares trade lower after Rs 856 crore block deal
By Aditya Bhagchandani Published on June 4, 2025, 09:31 IST Shares of Alkem Laboratories came into focus on Tuesday following a large block deal worth ₹856.39 crore executed on the BSE. The transaction involved the exchange of approximately 17.49 lakh shares at a price of ₹4,895.60 per share. Ahead of the trade, reports had indicated that Jayanti Sinha, a member of the promoter group, was planning to offload a 1.42% stake in the company. As per the March 2025 shareholding data, Sinha held a 2.46% stake in Alkem Laboratories. The block deal, executed at a floor price of ₹4,850, was offered at a nearly 3% discount to the last traded price. Promoters hold a controlling 55.1% stake in Alkem, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) own 9.4% and 19.4% stakes respectively. The public holds the remaining 16.1% of the equity. Financially, Alkem Labs reported a 4.2% year-on-year increase in net profit to ₹305.9 crore for the March quarter. Revenue rose 7.1% to ₹3,143.8 crore, but EBITDA margins saw a decline to 12.4% from 13.7% last year, leading to some investor disappointment. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Time of India
4 days ago
- Business
- Time of India
I-Sec maintains Add on Alkem Laboratories, revises target price to Rs 5,900
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel ICICI Securities maintains an Add call on Alkem Laboratories with a revised target price of Rs 5,900 (earlier Rs 5,920). The current market price of Alkem Laboratories is Rs 5065.15. Alkem Laboratories, incorporated in 1973, is a Large Cap company with a market cap of Rs 61014.02 crore, operating in the pharmaceuticals Laboratories' key products/revenue segments include Pharmaceuticals, Other Operating Revenue, Export Incentives and Scrap for the year ending the quarter ended 31-03-2025, the company has reported a Consolidated Total Income of Rs 3289.71 crore, down -5.12 % from last quarter Total Income of Rs 3467.27 crore and up 8.79 % from last year same quarter Total Income of Rs 3023.99 crore. The company has reported net profit after tax of Rs 323.01 crore in the latest company?s top management includes N Singh, Ravi, Singh, Kumar Purwar, Talwar, Singh, Kumar Singh, Singh, Singh, Singh, Kumar Aneja. Company has BSR & Co. LLP as its auditors. As on 31-03-2025, the company has a total of 12 crore shares Securities expects Alkem to witness revenue CAGR of 9.3% and nominal margin expansion of ~50bps to 19.9% over FY25-27E. They have reduced EPS by ~27% for FY27E to factor in higher tax rate. The stock trades at valuations of 27.3x FY26E and 33.0x FY27E earnings and EV/EBITDA multiple of 21.8x FY26E and 19.1x FY27E. The brokerage maintains ADD with lower target price of Rs 5,900 (earlier Rs 5,920) based on 22x FY27E EV/EBITDA (29x FY26E earnings earlier). Key downside risks include more products under price control, regulatory lapses in US-centric plants and slowdown in trade held 55.13 per cent stake in the company as of 31-Mar-2025, while FIIs owned 9.4 per cent, DIIs 19.42 per cent.
Economic Times
4 days ago
- Business
- Economic Times
I-Sec maintains Add on Alkem Laboratories, revises target price to Rs 5,900
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel ICICI Securities maintains an Add call on Alkem Laboratories with a revised target price of Rs 5,900 (earlier Rs 5,920). The current market price of Alkem Laboratories is Rs 5065.15. Alkem Laboratories, incorporated in 1973, is a Large Cap company with a market cap of Rs 61014.02 crore, operating in the pharmaceuticals Laboratories' key products/revenue segments include Pharmaceuticals, Other Operating Revenue, Export Incentives and Scrap for the year ending the quarter ended 31-03-2025, the company has reported a Consolidated Total Income of Rs 3289.71 crore, down -5.12 % from last quarter Total Income of Rs 3467.27 crore and up 8.79 % from last year same quarter Total Income of Rs 3023.99 crore. The company has reported net profit after tax of Rs 323.01 crore in the latest company?s top management includes N Singh, Ravi, Singh, Kumar Purwar, Talwar, Singh, Kumar Singh, Singh, Singh, Singh, Kumar Aneja. Company has BSR & Co. LLP as its auditors. As on 31-03-2025, the company has a total of 12 crore shares Securities expects Alkem to witness revenue CAGR of 9.3% and nominal margin expansion of ~50bps to 19.9% over FY25-27E. They have reduced EPS by ~27% for FY27E to factor in higher tax rate. The stock trades at valuations of 27.3x FY26E and 33.0x FY27E earnings and EV/EBITDA multiple of 21.8x FY26E and 19.1x FY27E. The brokerage maintains ADD with lower target price of Rs 5,900 (earlier Rs 5,920) based on 22x FY27E EV/EBITDA (29x FY26E earnings earlier). Key downside risks include more products under price control, regulatory lapses in US-centric plants and slowdown in trade held 55.13 per cent stake in the company as of 31-Mar-2025, while FIIs owned 9.4 per cent, DIIs 19.42 per cent.
Bloomberg
4 days ago
- Business
- Bloomberg
Indian Stocks Bullish Momentum Takes a Pause
Before the trading day starts we bring you a digest of the key news and events that are likely to move markets. Today we look at: Good morning, this is Chiranjivi Chakraborty, an equities reporter in Mumbai. Nifty futures point to a firm start for Indian equities this morning after three straight days of losses. Buoyant Asian stocks are likely to support gains in local shares. Meanwhile, more block deals are expected today, with founders and strategic investors in companies including Tata Technologies, Aditya Birla Fashion and Alkem Laboratories continuing to cash in on rich valuations.
Business Standard
29-05-2025
- Business
- Business Standard
Alkem Laboratories standalone net profit declines 14.78% in the March 2025 quarter
Sales decline 13.55% to Rs 2044.94 crore Net profit of Alkem Laboratories declined 14.78% to Rs 276.94 crore in the quarter ended March 2025 as against Rs 324.97 crore during the previous quarter ended March 2024. Sales declined 13.55% to Rs 2044.94 crore in the quarter ended March 2025 as against Rs 2365.37 crore during the previous quarter ended March 2024. For the full year,net profit rose 30.55% to Rs 2280.89 crore in the year ended March 2025 as against Rs 1747.15 crore during the previous year ended March 2024. Sales rose 10.67% to Rs 8813.44 crore in the year ended March 2025 as against Rs 7963.85 crore during the previous year ended March 2024. Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 2044.942365.37 -14 8813.447963.85 11 OPM % 14.5117.23 - 24.4620.98 - PBDT 391.47470.63 -17 2587.151897.10 36 PBT 299.83401.53 -25 2303.541657.96 39 NP 276.94324.97 -15 2280.891747.15 31
